These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 10077563

  • 21. SMRT isoforms mediate repression and anti-repression of nuclear receptor heterodimers.
    Chen JD, Umesono K, Evans RM.
    Proc Natl Acad Sci U S A; 1996 Jul 23; 93(15):7567-71. PubMed ID: 8755515
    [Abstract] [Full Text] [Related]

  • 22. Identification and characterization of a novel corepressor interaction region in RVR and Rev-erbA alpha.
    Burke LJ, Downes M, Laudet V, Muscat GE.
    Mol Endocrinol; 1998 Feb 23; 12(2):248-62. PubMed ID: 9482666
    [Abstract] [Full Text] [Related]

  • 23. Two receptor interacting domains in the nuclear hormone receptor corepressor RIP13/N-CoR.
    Seol W, Mahon MJ, Lee YK, Moore DD.
    Mol Endocrinol; 1996 Dec 23; 10(12):1646-55. PubMed ID: 8961273
    [Abstract] [Full Text] [Related]

  • 24. Alternative splicing determines the interaction of SMRT isoforms with nuclear receptor-DNA complexes.
    Faist F, Short S, Kneale GG, Sharpe CR.
    Biosci Rep; 2009 Jun 23; 29(3):143-9. PubMed ID: 18752469
    [Abstract] [Full Text] [Related]

  • 25. Structure-function analysis of the Rev-erbA and RVR ligand-binding domains reveals a large hydrophobic surface that mediates corepressor binding and a ligand cavity occupied by side chains.
    Renaud JP, Harris JM, Downes M, Burke LJ, Muscat GE.
    Mol Endocrinol; 2000 May 23; 14(5):700-17. PubMed ID: 10809233
    [Abstract] [Full Text] [Related]

  • 26. The silencing mediator of retinoic acid and thyroid hormone receptor (SMRT) corepressor is required for full estrogen receptor alpha transcriptional activity.
    Peterson TJ, Karmakar S, Pace MC, Gao T, Smith CL.
    Mol Cell Biol; 2007 Sep 23; 27(17):5933-48. PubMed ID: 17591692
    [Abstract] [Full Text] [Related]

  • 27. Estrogen receptors recruit SMRT and N-CoR corepressors through newly recognized contacts between the corepressor N terminus and the receptor DNA binding domain.
    Varlakhanova N, Snyder C, Jose S, Hahm JB, Privalsky ML.
    Mol Cell Biol; 2010 Mar 23; 30(6):1434-45. PubMed ID: 20065040
    [Abstract] [Full Text] [Related]

  • 28. SMRTER, a Drosophila nuclear receptor coregulator, reveals that EcR-mediated repression is critical for development.
    Tsai CC, Kao HY, Yao TP, McKeown M, Evans RM.
    Mol Cell; 1999 Aug 23; 4(2):175-86. PubMed ID: 10488333
    [Abstract] [Full Text] [Related]

  • 29. A nuclear hormone receptor corepressor mediates transcriptional silencing by receptors with distinct repression domains.
    Zamir I, Harding HP, Atkins GB, Hörlein A, Glass CK, Rosenfeld MG, Lazar MA.
    Mol Cell Biol; 1996 Oct 23; 16(10):5458-65. PubMed ID: 8816459
    [Abstract] [Full Text] [Related]

  • 30. A novel thyroid hormone receptor-beta mutation that fails to bind nuclear receptor corepressor in a patient as an apparent cause of severe, predominantly pituitary resistance to thyroid hormone.
    Wu SY, Cohen RN, Simsek E, Senses DA, Yar NE, Grasberger H, Noel J, Refetoff S, Weiss RE.
    J Clin Endocrinol Metab; 2006 May 23; 91(5):1887-95. PubMed ID: 16464943
    [Abstract] [Full Text] [Related]

  • 31. The corepressor N-CoR and its variants RIP13a and RIP13Delta1 directly interact with the basal transcription factors TFIIB, TAFII32 and TAFII70.
    Muscat GE, Burke LJ, Downes M.
    Nucleic Acids Res; 1998 Jun 15; 26(12):2899-907. PubMed ID: 9611234
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The partial agonist activity of antagonist-occupied steroid receptors is controlled by a novel hinge domain-binding coactivator L7/SPA and the corepressors N-CoR or SMRT.
    Jackson TA, Richer JK, Bain DL, Takimoto GS, Tung L, Horwitz KB.
    Mol Endocrinol; 1997 Jun 15; 11(6):693-705. PubMed ID: 9171233
    [Abstract] [Full Text] [Related]

  • 34. The functional relationship between co-repressor N-CoR and SMRT in mediating transcriptional repression by thyroid hormone receptor alpha.
    Choi KC, Oh SY, Kang HB, Lee YH, Haam S, Kim HI, Kim K, Ahn YH, Kim KS, Yoon HG.
    Biochem J; 2008 Apr 01; 411(1):19-26. PubMed ID: 18052923
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Ski-interacting protein, a bifunctional nuclear receptor coregulator that interacts with N-CoR/SMRT and p300.
    Leong GM, Subramaniam N, Issa LL, Barry JB, Kino T, Driggers PH, Hayman MJ, Eisman JA, Gardiner EM.
    Biochem Biophys Res Commun; 2004 Mar 19; 315(4):1070-6. PubMed ID: 14985122
    [Abstract] [Full Text] [Related]

  • 38. JMJD2A is a novel N-CoR-interacting protein and is involved in repression of the human transcription factor achaete scute-like homologue 2 (ASCL2/Hash2).
    Zhang D, Yoon HG, Wong J.
    Mol Cell Biol; 2005 Aug 19; 25(15):6404-14. PubMed ID: 16024779
    [Abstract] [Full Text] [Related]

  • 39. Cell-specific inhibition of retinoic acid receptor-alpha silencing by the AF2/tau c activation domain can be overcome by the corepressor SMRT, but not by N-CoR.
    Baniahmad A, Dressel U, Renkawitz R.
    Mol Endocrinol; 1998 Apr 19; 12(4):504-12. PubMed ID: 9544986
    [Abstract] [Full Text] [Related]

  • 40. The nuclear receptor corepressor N-CoR regulates differentiation: N-CoR directly interacts with MyoD.
    Bailey P, Downes M, Lau P, Harris J, Chen SL, Hamamori Y, Sartorelli V, Muscat GE.
    Mol Endocrinol; 1999 Jul 19; 13(7):1155-68. PubMed ID: 10406466
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.